Swiss companies are world leaders in innovation spending
Switzerland has been crowned the world’s most innovative country for eighth year in a row by theGeneva-based World Intellectual Property Organization (WIPO).
Keystone
This content was published on
2 minutes
SDA-ATS/ds
العربية
ar
ريادة عالمية للشركات السويسرية في الإنفاق على الإبتكار
Swiss companies are at the front of the pack when it comes to investing in research and development (R&D) worldwide, according to a global business survey.
Accounting and consulting firm Ernst & Young (EY) found that Swiss companies spend 6.6% of their turnover on R&D, compared with an average of 3.8% worldwide.
The authors of the study, which was published on Thursday, analysed the investments of the 500 top-spending international companies in R&D. Expenditure in the sector increased by 6 percent in 2017 to 532 billion euros (CHF 601 billion), the report found, while two-thirds of the companies boosted research spending.
“Investment in research and development is increasing worldwide because rapid technological progress, ever shorter product cycles and rapidly changing consumer demands are driving companies to innovate,” explained Marcel Stalder, chief executive officer of EY Switzerland.
The Swiss companies in the selection earmarked the largest share of their turnover (6.6% in 2017) to research and development, ahead of competitors from the United States (5.9%), Sweden (4.4%), and Germany (4.1%).
The results show that Swiss companies have recognised early “the importance of innovation for their long-term international competitiveness and the need for high margins”, the study said.
Digital and pharma in the spotlight
In absolute terms, the top of the ranking is occupied by tech giants Amazons and Alphabet (Google’s parent company).
In Europe, the Volkswagen automotive group is the top spender, with an R&D budget of 11.6 billion euros in 2017.
Pharmaceutical companies are also well ranked, with Roche, Johnson & Johnson, and Merck & Co all making the top 10.
In all, eleven of the top 500 companies are Swiss, and their combined R&D investments came to some 23 billion euros in 2017.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
This content was published on
Apple's iPhones have gained further market share in Switzerland. Around half of all smartphone owners used a model from the US tech giant last year.
Switzerland receives poor marks in fight against public sector corruption
This content was published on
Switzerland is not improving in the fight against corruption according to the Corruption Perceptions Index published by Transparency International.
Swiss army identifies gaps in civil aircraft collision warning system
This content was published on
The Cyber-Defence Campus of the Swiss defence ministry has found two vulnerabilities in the collision warning system for civil aviation.
Swiss parents rely on savings accounts for their children instead of investment funds
This content was published on
According to the survey, over 60% of parents start saving in the first year of life, and around 10% even before the child is born.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss sign agreement to build China’s first zero-energy building
This content was published on
The project called “Swiss House Sunlon” is backed by Swiss companies and will be the first zero energy dwelling in China. The technology used in the building will come from the Swiss cleantech sector and is meant to serve as a showcase for Swiss innovation in the country. The agreement was signed on Thursday in…
The enigma explorations of Bruce Nauman at Schaulager
This content was published on
An ambitious retrospective of the elusive American artist runs alongside Art Basel and showcases works that trouble, amuse, shock and delight.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.